![Charles Baum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Baum
Direktor/Vorstandsmitglied bei
PMV PHARMACEUTICALS, INC.
Vermögen: 14 986 $ am 31.05.2026
Profil
Dr. Charles M. Baum ist Chairman bei Oncomyx Therapeutics, Inc. und President, Chief Executive Officer & Director bei Mirati Therapeutics, Inc. Er ist Mitglied des Board of Directors von PMV Pharmaceuticals, Inc., BCTG Acquisition Corp. und Mirati Therapeutics, Inc. Dr. Baum war zuvor als unabhängiger Direktor bei Immunomedics, Inc. beschäftigt, als unabhängiger Direktor bei Array BioPharma, Inc. und als Senior VP-Biotherapeutic Clinical Research bei Pfizer Inc. Er erhielt seinen Doktortitel von der Washington University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.05.2026 | 9.366 ( 0,02 % ) | 14 986 $ | 31.05.2026 | |
| 04.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Charles Baum
| Unternehmen | Position | Beginn |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.04.2021 |
| ACRIVON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 22.06.2023 |
Oncomyx Therapeutics, Inc.
 Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and operates software platform to orchestrate an immune response & treat cancer | Vorsitzender | 06.11.2020 |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Vorstandsvorsitzender | 25.07.2024 |
Crossbow Therapeutics, Inc.
 Crossbow Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops antibodies for cancer treatment | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Charles Baum
| Unternehmen | Position | Ende |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 08.01.2025 |
| MIRATI THERAPEUTICS | Vorstandsvorsitzender | 23.01.2024 |
| TANGO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.01.2021 |
| IMMUNOMEDICS, INC. | Direktor/Vorstandsmitglied | 23.10.2020 |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Charles Baum
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Oncomyx Therapeutics, Inc.
Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and operates software platform to orchestrate an immune response & treat cancer | Technology Services |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases | Health Technology |
BCTG Acquisition Corp.
 BCTG Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
Crossbow Therapeutics, Inc.
Crossbow Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops antibodies for cancer treatment | Health Technology |
